Roiver Score™ for
HKPDCellyan Biotechnology Co., Ltd Class A Ordinary Shares
Based on fundamentals through 12/31/2026.
As of December 31, 2026, Cellyan Biotechnology Co., Ltd Class A Ordinary Shares (HKPD) scores 0/100 (Weak) on the Roiver Score — a transparent quality composite. Its strongest area is profitability; its weakest is stability. The score measures business quality, not timing — it's a signal, not a recommendation.
No black box
Roiver Score is a transparent 0–100 quality composite. Five components, each 0–20: profitability, capital structure, cash quality, valuation, and stability. Inspired by Piotroski's F-Score, Altman's Z-Score, and the Buffett/Munger framework on quality compounders at fair prices. Read the full methodology →
Frequently asked about HKPD
What is HKPD's Roiver Score?
Cellyan Biotechnology Co., Ltd Class A Ordinary Shares scores 0 out of 100 (Weak) as of December 31, 2026, based on fundamentals.
How is the Roiver Score for HKPD calculated?
It sums five 0–20 components — profitability, capital structure, cash quality, valuation, and stability — into a transparent 0–100 composite. The full methodology is published.
Is HKPD a good quality stock?
On quality, HKPD rates "Weak" (0/100). Its strongest driver is profitability and its weakest is stability. Quality is one input to a decision, not a buy/sell call.
Embed on your site
Drop this iframe into a Substack, blog post, or notion page. Updates automatically as fundamentals change.
<iframe src="https://roiver.com/embed/score/HKPD" width="640" height="280" frameborder="0" style="border:0;border-radius:16px;overflow:hidden" loading="lazy"></iframe>
Get HKPD's Score in your inbox
A free weekly digest of quality scores and what changed. No account needed.
Educational use only. Roiver Score is a quality signal, not a recommendation.